Who Owns Coya Therapeutics Stock?
NASDAQ: COYAHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 33.26%
- Held by insiders
- 14.69%
- Institutional holders
- 62
- Institutions 33.3%
- Insiders 14.7%
- Public and other 52.1%
Who owns Coya Therapeutics stock?
Institutional investors own about 33.3% of Coya Therapeutics's shares, spread across 62 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 14.69% of COYA.
The largest institutional holders are DME Capital Management, LP (9.96%), Vanguard Capital Management LLC (3.59%) and Alyeska Investment Group, L.p. (3.41%). Together, the top 10 institutions control 26.6% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their COYA positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of COYA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| DME Capital Management, LP | 2.34M | 9.96% | 0.0% |
| Vanguard Capital Management LLC | 842.22K | 3.59% | -0.3% |
| Alyeska Investment Group, L.p. | 800.00K | 3.41% | 0.0% |
| AIGH Capital Management LLC | 631.91K | 2.69% | -35.2% |
| CM Management, LLC | 400.00K | 1.71% | +6.7% |
| Private Management Group, Inc. | 384.22K | 1.64% | +4.1% |
| Marshall Wace LLP | 249.79K | 1.06% | +10.6% |
| Geode Capital Management, LLC | 228.24K | 0.97% | -2.2% |
| Renaissance Technologies, LLC | 192.99K | 0.82% | +85.6% |
| Prosight Management, Lp | 170.00K | 0.72% | -59.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of COYA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 601.12K | 2.56% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 219.96K | 0.94% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 105.40K | 0.45% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 75.56K | 0.32% |
| iShares Trust-iShares Micro-Cap ETF | 65.47K | 0.28% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 37.16K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 32.36K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 31.13K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 14.89K | 0.06% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | 13.11K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Coya Therapeutics?
DME Capital Management, LP is the largest institutional shareholder of COYA, owning 9.96% of shares outstanding (2.34M shares) as of its latest 13F filing.
What percentage of Coya Therapeutics is owned by institutions?
Institutions own about 33.3% of COYA shares and 39.0% of the public float.
How much of Coya Therapeutics do insiders own?
Insiders, such as officers and directors, own about 14.69% of COYA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.